Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 290OTHER 232OTHER_GOV 8NIH 7NETWORK 5FED 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Neoplasms × Clear all
NCT01285219 2011-01-27

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

ChineseAMS

Phase 3 Completed
337 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡